The rat T-cell surface protein RT6 is associated with src family tyrosine kinases and generates an activation signal

Diabetes

Volumn 45, Issue 10, 1996, Pages 1419-1426

  Rigby, Mark R ^a   Bortell, Rita ^a   Greiner, Dale L ^a   Czech, Michael P ^a   Klarlund, Jes K ^a   Mordes, John P ^a   Rossini, Aldo A ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Diabetes Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; DIABETES MELLITUS; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0029744326     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.10.1419     Document Type: Article

References (53)

1. Koch F, Thiele HG, Low MG: Release of the rat T-cell alloantigen RT-6.2 from cell membranes by phosphatidylinositol-specific phospholipase C. J Exp Med 164:1338-1343, 1986
2. a gene is transcribed and translated in lymphopenic diabetes-prone BB rats. Diabetes 42:688-695, 1993
3. Haag F, Koch F, Thiele H-G: Nucleotide and deduced amino acid sequence of the rat T-cell alloantigen RT6.1. Nucleic Acids Res 18:1047, 1990
4. Koch F, Haag F, Kashan A, Thiele H-G: Primary structure of rat RT6.2, a nonglycosylated phosphatidylinositol-linked surface marker of postthymic T-cells. Proc Natl Acad Sci USA 87:964-967, 1990
5. Koch F, Kashan A, Thiele H-G: The rat T-cell differentiation marker RT6.1 is more polymorphic than its alloantigenic counterpart RT6.2. Immunology 65:259-265, 1988
6. Thiele H-G, Koch F, Hamann A, Arndt R: Biochemical characterization of the T-cell alloantigen RT-6.2. Immunology 59:195-201, 1986
7. Takada T, Iida K, Moss J: Expression of NAD glycohydrolase activity by rat mammary adenocarcinoma cells transformed with rat T-cell alloantigen RT6.2. J Biol Chem 269:9420-9423, 1994
8. Haag F, Andresen V, Karsten S, Koch-Nolte F, Thiele H-G: Both allelic forms of the rat T-cell differentiation marker RT6 display nicotinamide adenine dinucleotide (NAD)-glycohydrolase activity, yet only RT6.2 is capable of automodificatiori upon incubation with NAD. Eur J Immunol 25:2355-2361, 1995
9. +:arginine ADP-ribosyltransferases with auto-ADP-ribosylation activity. J Immunol 156:4259-4265, 1996
10. Koch F, Haag F, Thiele H-G: Nucleotide and deduced amino acid sequence for the mouse homologue of the rat T-cell differentiation marker RT6. Nucleic Acids Res 18:3636, 1990
11. Prochazka M, Gaskins HR, Leiter EH, Koch-Nolte F, Haag F, Thiele H-G: Chromosomal localization, DNA polymorphism, and expression of Rt-6, the mouse homologue of rat T-lymphocyte differentiation marker RT6. Immunogenetics 33:152-156, 1991
12. 1 mice. Int. Immunol 7:883-890, 1995
13. Haag F, Koch-Nolte F, Kühl M, Lorenzen S, Thiele H-G: Premature stop codons inactivate the RT6 genes of the human and chimpanzee species. J Mol. Biol 243:537-546, 1994
14. + subset. Cell Immunol 114:336-346, 1988
15. Sarkar P, Crisá L, McKeever U, Bortell R, Handler ES, Mordes JP, Waite DJ, Schoenbaum A, Haag F, Koch-Nolte F, Thiele H-G, Greiner DL, Rossini AA: Loss of RT6 message and most circulating T-cells after thymectomy of diabetes prone BB rats. Autoimmunity 18:15-22, 1994
16. Crisá L, Mordes JP, Rossini AA: Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev 8:9-37, 1992
17. Guberski DL: Diabetes-prone and diabetes-resistant BB rats: animal models of spontaneous and virally induced diabetes mellitus, lyniphocytic thyroiditis, and collagen-induced arthritis. ILAR News 35:29-37, 1994
18. White RA, Mason DW, Williams AF, Galfre G, Milstein C: T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody. J Exp Med 148:664-673, 1978
19. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL: An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142:257-265, 1991
20. Tamura GS, Dailey MO, Gallatin WM, McGrath MS, Weissman IL, Pillemer EA: Isolation of molecules recognized by monoclonal antibodies and antisera: the solid phase immunoisolation technique. Anal Biochem 136:458-464, 1984
21. Siegel S: Nonparametric Statistics. New York, McGraw-Hill, 1956
22. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:683-698, 1984
23. Bolen JB, Rowley RB, Spana C, Tsygankov AY: The Src family of tyrosine protein kinases in hemopoietic signal transduction. [Review]. FASEB J 6:3403-3409, 1992
24. Veillette A, Horak ID, Bolen JB: Post-translational alterations of the tyrosine kinase p561ck in response to activators of protein kinase C. Oncogene Res 2:385-401, 1988
25. Kroczek RA, Gunter KC, Seligmann B, Shevach EM: Induction of T-cell activation by monoclonal anti-Thy-1 antibodies. J Immunol 136:4379-4384, 1986
26. Gunter KC, Malek TR, Shevach EM: T-cell-activating properties of an anti-Thy-1 monoclonal antibody: possible analogy to OKT3/Leu-4. J Exp Med 159:716-730, 1984
27. + T-cells. J Immunol 143:407-413, 1989
28. Malek TR, Ortega G, Chan C, Kroczek RA, Shevach EM: Role of Ly-6 in lymphocyte activation. II. Induction of T-cell activation by monoclonal anti-Ly-6 antibodies. J Exp Med 164:709-722, 1986
29. Rock KL, Reiser H, Bamezai A, McGrew J, Benacerraf B: The LY-6 locus: a multigene family encoding phosphatidylinositol-anchored membrane proteins concerned with T-cell activation. [Review]. Immunol Rev 111:195-224, 1989
30. Davis LS, Patel SS, Atkinson JP, Lipsky PE: Decay-accelerating factor functions as a signal transducing molecule for human T-cells. J Immunol 141:2246-2252, 1988
31. Korty PE, Brando C, Shevach EM: CD59 functions as a signal-transducing molecule for human T-cell activation. J Immunol 146:4092-4098, 1991
32. Thomson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, Low MG, Massaia M, Lucas AH: Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tiss Antigen 35:9-19, 1990
33. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. [Review]. Cell 76:263-274, 1994
34. Malissen B, Schmitt-Verhulst AM: Transmembrane signalling through the T-cell-receptor-CD3 complex. [Review]. Curr Opin Immunol 5:324-333, 1993
35. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. [Review]. Cell 76:253-262, 1994
36. Stefanova I, Horejsi V, Ansotegui U, Knapp W, Stockinger H: GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016-1019, 1991
37. Tyn protein tyrosine kinase in T-cells. J Biol Chem 267:12317-12322, 1992
38. Shenoy-Scaria AM, Kwong J, Fujita T, Olszowy MW, Shaw AS, Lublin DM: Signal transduction through decay-accelerating factor: interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p561ck and p59fyn 1. J Immunol 149:3535-3541, 1992
39. Robinson PJ: Phosphatidylinositol membrane anchors and T-cell activation. [Review], Immunol Today 12:35-41, 1991
40. Brown D: The tyrosine kinase connection: how GPI-anchored proteins activate T-cells. [Review]. Curr Opin Immunol 5:349-354, 1993
41. Malek TR, Fleming TJ, Codias EK: Regulation of T lymphocyte function by glycosylphosphatidylinositol (GPI)-anchored proteins. [Review]. Semin Immunol 6:105-113, 1994
42. Davis S, Aldrich TH, Valenzuela DM, Wong W, Furth ME, Squinto SP: The receptor for ciliary neurotrophic factor. Science 253:59-63, 1991
43. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD: CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121-1132, 1992
44. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B: Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 179:1337-1342, 1994
45. Vandenberghe P, Ceuppens JL: Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T-cell growth: evidence for signal transduction through CD5. Eur J Immunol 21:251-259, 1991
46. Bott CM, Doshi JB, Morimoto C, Romain PL, Fox DA: Activation of human T-cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein. Int Immunol 5:783-792, 1993
47. Jung LK, Roy AK, Chakkalath HR: CD7 augments T-cell proliferation via the interleukin-2 autocrine pathway. Cell Immunol 141:189-199, 1992
48. Lu Y, Granelli-Pipemo A, Bjorndahl JM, Phillips CA, Trevillyan JM: CD28-induced T-cell activation: evidence for a protein-tyrosine kinase signal transduction pathway. J Immunol 149:24-29, 1992
49. Watts JD, Sanghera JS, Pelech SL, Aebersold R: Phosphorylation of serine 59 of p561ck in activated T-cells. J Biol Chem 268:23275-23282, 1993
50. Soula M, Rothhut B, Camoin L, Guillaume JL, Strosberg D, Vorherr T, Meggio F, Fischer S, Fagard R: Anti-CD3 and phorbol ester induce distinct phosphorylated sites in the SH2 domain of p561ck. J Biol Chem 268:27420-27427, 1993
51. Luo KX, Sefton BM: Analysis of the sites in p561ck whose phosphorylation is induced by tetradecanoyl phorbol acetate. Oncogene 5:803-808, 1990
52. Hurley TR, Luo K, Sefton BM: Activators of protein kinase C induce dissociation of CD4, but not CD8, from p561ck. Science 245:407-409, 1989
53. Gupta S, Weiss A, Kumar G, Wang S, Nel A: The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase: evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J Biol Chem 269:17349-17357, 1994